These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8156965)

  • 1. Zonisamide-induced behavior disorder in two children.
    Kimura S
    Epilepsia; 1994; 35(2):403-5. PubMed ID: 8156965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A five-year-old girl with epilepsy showing forced normalization due to zonisamide].
    Hirose M; Yokoyama H; Haginoya K; Iinuma K
    No To Hattatsu; 2003 May; 35(3):259-63. PubMed ID: 12755059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of valproate, phenytoin, and zonisamide on clonic and tonic seizures induced by acute and repeated exposure of mice to flurothyl.
    Hashimoto Y; Araki H; Futagami K; Kawasaki H; Gomita Y
    Physiol Behav; 2003 Mar; 78(3):465-9. PubMed ID: 12676283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing serum concentration of zonisamide in epileptic patients.
    Kimura M; Tanaka N; Kimura Y; Miyake K; Kitaura T; Fukuchi H; Harada Y
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):193-5. PubMed ID: 1576673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy.
    Kondo T; Kaneko S; Amano Y; Egawa I
    Epilepsia; 1996 Dec; 37(12):1242-4. PubMed ID: 8956859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combined administration of zonisamide and valproic acid or phenytoin to nitric oxide production, monoamines and zonisamide concentrations in the brain of seizure-susceptible EL mice.
    Nagatomo I; Akasaki Y; Uchida M; Tominaga M; Hashiguchi W; Takigawa M
    Brain Res Bull; 2000 Sep; 53(2):211-8. PubMed ID: 11044598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center.
    Kim HL; Aldridge J; Rho JM
    J Child Neurol; 2005 Mar; 20(3):212-9. PubMed ID: 15832611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental and therapeutic pharmacology of antiepileptic drugs.
    Miura H
    Epilepsia; 2000; 41 Suppl 9():2-6. PubMed ID: 11156504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy.
    Marinas A; Villanueva V; Giráldez BG; Molins A; Salas-Puig J; Serratosa JM
    Epileptic Disord; 2009 Mar; 11(1):61-6. PubMed ID: 19264587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA and IgG2 deficiency associated with zonisamide therapy: a case report.
    Maeoka Y; Hara T; Dejima S; Takeshita K
    Epilepsia; 1997 May; 38(5):611-3. PubMed ID: 9184608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonisamide: pharmacokinetics, efficacy, and adverse events in children with epilepsy.
    Wallander KM; Ohman I; Dahlin M
    Neuropediatrics; 2014 Dec; 45(6):362-70. PubMed ID: 25133701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective mutism and obsessive compulsive disorders associated with zonisamide.
    Hirai K; Kimiya S; Tabata K; Seki T; Jozaki K; Kumagai N
    Seizure; 2002 Oct; 11(7):468-70. PubMed ID: 12237077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotic episodes during zonisamide treatment.
    Miyamoto T; Kohsaka M; Koyama T
    Seizure; 2000 Jan; 9(1):65-70. PubMed ID: 10667966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding.
    Tasaki K; Minami T; Ieiri I; Ohtsubo K; Hirakawa Y; Ueda K; Higuchi S
    Brain Dev; 1995; 17(3):182-5. PubMed ID: 7573757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The necessity of adjusting the dosage of zonisamide when coadministered with other anti-epileptic drugs.
    Shinoda M; Akita M; Hasegawa M; Hasegawa T; Nabeshima T
    Biol Pharm Bull; 1996 Aug; 19(8):1090-2. PubMed ID: 8874824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zonisamide: review of its use in epilepsy therapy.
    Zareba G
    Drugs Today (Barc); 2005 Sep; 41(9):589-97. PubMed ID: 16341290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonisamide in epilepsy: a pilot study.
    Wilensky AJ; Friel PN; Ojemann LM; Dodrill CB; McCormick KB; Levy RH
    Epilepsia; 1985; 26(3):212-20. PubMed ID: 4006880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Our clinical experience with zonisamide in resistant generalized epilepsy syndromes.
    Kelemen A; Rásonyl G; Neuwirth M; Barcs G; Szucs A; Jakus R; Fabó D; Juhos V; Pálfy B; Halász P
    Ideggyogy Sz; 2011 Mar; 64(5-6):187-92. PubMed ID: 21688720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.